All Stories

  1. Patients with systemic sclerosis frequently use phytopharmaceuticals: a cross-sectional survey
  2. Skin and lung fibrosis induced by bleomycin in mice: a systematic review
  3. Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results
  4. Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry
  5. How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?
  6. Rheumatological patients’ knowledge of, beliefs about, and practices in using phytotherapy: an exploratory study
  7. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry
  8. Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
  9. POS0628 BARICITINIB AMELIORATES BLEOMYCIN-INDUCED PULMONARY AND SKIN FIBROSIS VIA JAK 1/2 INHIBITON
  10. POS0199-PARE RHEUMATOLOGICAL PATIENTS’ KNOWLEDGE OF, BELIEFS ABOUT, AND PRACTICES IN USING PHYTOTHERAPY: AN EXPLORATORY STUDY
  11. Vitamin D attenuates elevated oxidative DNA damage in scleroderma patients with organ involvement: A prospective study
  12. Assessment of diaphragmatic function by ultrasonography in patients with systemic sclerosis and its relation to clinical parameters
  13. Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology
  14. Evaluation of Choroidal Vascularity Index in Systemic Sclerosis Patients
  15. Evaluation of Acute Phase Reactants in Patients with Ankylosing Spondylitis
  16. Evaluation of middle ear and hearing status of ankylosing spondylitis patients with wideband tympanometry and pure tone audiometry tests
  17. Comparison of pulmonary function, respiratory symptoms, functional level, and health-related quality of life in patients with systemic sclerosis according to smoking status
  18. Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis
  19. Warthin tumour and IgG-4-RD with pleural involvement: shared immunity or coincidence?
  20. Global hypomethylation pattern in systemic sclerosis: An application for absolute quantification of epigenetic DNA modification products by 2D-UPLC-MS/MS
  21. POS0001 CAN SINGLE IMPUTATION TECHNIQUES FOR BASDAI COMPONENTS RELIABLY CALCULATE THE COMPOSITE SCORE IN AXIAL SPONDYLOARTHRITIS PATIENTS?
  22. AB1088 COVID-19 VACCINATION OF SPONDYLOARTHRITIS PATIENTS RECEIVING BIOLOGICAL THERAPY: REAL-LIFE DATA
  23. AB1312 HIGH PREVALENCE OF iRMD IN SARCOIDOSIS PATIENTS
  24. AB1106 HOW HAS THE COVID-19 PANDEMIC AFFECTED OUR RHEUMATOLOGY PATIENTS USING BIOLOGICAL/TARGETED DMARDS?
  25. AB0762 Incidence Of Anterior Uveitis In Axial Spondyloarthritis During Secukinumab Treatment: TWO YEARS REAL LIFE EXPERIENCE FROM TURKBIO REGISTRY
  26. AB1295 TREATMENT OUTCOMES OF ADULT-ONSET STILL’S DISEASE PATIENTS WITH BIOLOGICAL THERAPY
  27. AB0769 Treatment outcomes of patients with biological therapy during pregnancy and effect of pregnancy planning on treatment preferance of rheumatologists
  28. Rituximab on lung, skin, and joint involvement in patients with systemic sclerosis: A case series study and review of the literature
  29. A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry
  30. Training Course Results of the Assessment of Modified Rodnan Skin Score in Scleroderma
  31. Protective effects of alpha-lipoic acid on bleomycin-induced skin fibrosis through the repression of NADPH Oxidase 4 and TGF-β1/Smad3 signaling pathways
  32. Pulmonary to Systemic Flow Ratio in Precapillary Pulmonary Hypertension Without Left-to-Right Shunts: A Prognostic Implication of the Fick Method
  33. The prevalence of Sjögren’s syndrome and sicca symptoms in patients with systemic sclerosis and alpha-smooth muscle actin expression in biopsy specimens from minor salivary glands
  34. Effects of supervised exercise program and home exercise program in patients with systemic sclerosis: A randomized controlled trial
  35. Association of Leptin Levels and Disease Activity in Patients with Early Rheumatoid Arthritis
  36. A preliminary study of possible fibrotic role of meprin metalloproteases in scleroderma patients
  37. AB0459 ARTICULAR INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS
  38. AB0708 HIGH DRUG RETENTION RATES DESPITE B/TSDMARD INTERRUPTIONS IN COVID-19 PANDEMIC CHAOS
  39. AB0437 OESOPHAGEAL DILATATION ON HIGH-RESOLUTION CT CHEST IN SYSTEMIC SCLEROSIS: SIGNIFICANT INDEX?
  40. POS0750 THE CHARACTERISTICS OF SYSTEMIC LUPUS ERYTHEMATOSUS WHO HAVE CONSTITUTIONAL SYMPTOMS AND LYMPHADENOPATHY
  41. Fatigue and its relationship with disease-related factors in patients with systemic sclerosis: A cross-sectional study
  42. Evaluation of limited hand mobility in systemic sclerosis patients by using “prayer sign” and “tabletop sign”
  43. Association between core stability and physical function, functional performance in patients with systemic sclerosis
  44. Postural balance and fall risk in patients with systemic sclerosis: A cross-sectional study
  45. TNF-α Inhibitors for the Management of Intractable Corneal Melt: Report of Three Cases and Review of the Literature
  46. Relationship of Wnt pathway activity and organ involvement in scleroderma types
  47. AB1071 COEXISTENCE OF FAMILIAL MEDITERRANEAN FEVER WITH SPONDYLOARTHRITIS: CLINICAL CHARACTERISTIC AND TREATMENT OUTCOMES
  48. AB0618 COMPREHENSIVE ANALYSIS OF AUTOANTIBODY PROFILE IN A TURKISH SYSTEMIC SCLEROSIS COHORT
  49. THU0378 DO COMORBIDITIES DECREASE THE FIRST TNF-INHIBITOR RETENTION AND TREATMENT RESPONSE IN AXIAL SPONDYLOARTHRITIS PATIENTS? DATA FROM TURKBIO
  50. SAT0097 DO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO
  51. SAT0344 LIMITED JOINT MOBILITY OF HAND IN SYSTEMIC SCLEROSIS PATIENTS BY USING “PRAYER” AND “TABLE TOP” SIGNS
  52. SAT0423 LONG-TERM SURVIVAL OF THE FIRST BIOLOGIC TREATMENT IN PSORIATIC ARTHRITIS AND THE EFFECT OF THE SELECTED TREATMENT ON DRUG SURVIVAL; TURKBIO REGISTRY
  53. FRI0099 THE IMPACT OF BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS ON THE COURSE OF RHEUMATOID ARTHRITIS-ASSOCIATED LUNG DISEASE
  54. THU0390 THE INFLUENCE OF OBESITY ON RETENTION AND TREATMENT RESPONSE OF SECUKINUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: REAL LIFE DATA FROM THE TURKBIO REGISTRY
  55. SAT0544 USE OF BIOLOGICAL DMARDS IN PATIENTS WITH ADULT-ONSET STILL’S DISEASE: RESULTS FROM TURKBIO REGISTRY
  56. Adult-onset still's disease, an unusual cause of severe acute liver injury: A case report
  57. Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
  58. FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE
  59. THU0690 DISEASE ACTIVITY CORRELATES WITH INSULIN RESISTANCE AND ADIPOCYTOKINES IN PATIENTS WITH DMARD-NAÏVE RHEUMATOID ARTHRITIS 
  60. AB1413-HPR FACTORS AFFECTING ACTIVITIES OF DAILY LIVING IN WOMEN INDIVIDUALS WITH SCLERODERMA
  61. AB0644 RESULTS OF A TRAINING COURSE FOR CALCULATION OF THE MODIFIED RODNAN SKIN SCORE IN SCLERODERMA
  62. THU0726-HPR THE COMPARISON OF ARTERIAL STIFFNESS, FUNCTIONAL EXERCISE CAPACITY AND PHYSICAL ACTIVITY IN SYSTEMIC SCLEROSIS AND HEALTHY INDIVIDUALS
  63. FRI0416 THE EFFICACY AND SAFETY OF ANTI-TNF A TREATMENT IN ANKYLOSING SPONDYLITIS PATIENTS WITH LATE ONSET COMPARED TO THOSE WITH ADULT ONSET; THE DATA FROM TURKBIO REGISTRY
  64. AB1378-HPR EFFECT OF CLINICAL CHARACTERISTICS, HABITS, PHYSICAL ACTIVITY LEVELS AND FUNCTIONAL CAPACITY ON QUALITY OF LIFE IN SYSTEMIC SCLEROSIS PATIENTS
  65. SAT0625 TREATMENT RESPONSE AND DRUG RETENTION RATES IN 23,956 BIOLOGIC-NAÏVE PATIENTS WITH AXIAL SPONDYLOARTHRITIS INITIATING TNFI TREATMENT – ROUTINE CARE DATA FROM 12 REGISTRIES IN THE EUROSPA COLLABORATION
  66. Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?
  67. Ochronosis Involvement and Extensity With 18F-FDG PET/CT
  68. The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society
  69. Antioxidant Effect of Epigallocatechin-3-Gallate in a Bleomycin-Induced Scleroderma Model
  70. Infliximab-associated focal segmental glomerulosclerosis in a patient with ankylosing spondylitis
  71. Gender does not make a difference in “composite psoriatic disease activity index (CPDAI)” in patients with psoriatic arthritis
  72. Association between Skin Thickness Measurements with Corneal Biomechanical Properties and Dry Eye Tests in Systemic Sclerosis
  73. Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: a potential multifaceted relationship between OPG/RANKL/TRAIL and Wnt inhibitors
  74. AB0860 Acute phase reactant change in ankylosing spondylitis patients
  75. FRI0105 Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis
  76. THU0317 Creating a european database of psoriatic arthritis patients treated in routine care – first, preliminary results from the eurospa research network collaboration
  77. AB0922 Metabolic syndrome is associated with active disease in psoriatic arthritis and may contribute to development of syndesmophytes
  78. AB0182 Molecular mechanisms mediating antioxidant effect of epigallocatechin-3-gallate in experimental scleroderma model
  79. AB0482 Similar efficacy of tofacitinib on disease activity in rheumatoid arthritis patients with and without previous biologicals; results from the turkbio registry
  80. THU0218 The efficacy and drug survival of the biosimilar infliximab (CT-P13) compared to the original reference infliximab in inflammatory rheumatic diseases; results from the turkbio registry
  81. AB0183 Vitamin d and vitamin d receptor in patients with scleroderma subtypes
  82. Effects of epigallocatechin-3-gallate (EGCG) on a scleroderma model of fibrosis
  83. Histopathological differences between primary Sjögren's syndrome and Sjögren's syndrome accompanied by scleroderma
  84. Parenchymal neuro-Behçet disease with erectile dysfunction and micturition disturbances: case report and literature review
  85. Focal myositis: a rare case report
  86. AB0658 Factors influencing elapsed time to a definitive diagnosis of systemic sclerosis and their relationship with the number of attending physicians and their medical specialization
  87. THU0714 Investigating the effects of hypermobility on balance variables
  88. AB0168 Protective effects of epigallocatechin 3 gallate on fibrosis in scleroderma model
  89. THU0314 Radiologic activity is the major determinant for physicians while deciding active disease in takayasu arteritis
  90. THU0271 The performance of different classification criteria in patients with primary sjogren's syndrome and analysis of their contribution for definitive diagnosis, when either criteria used alone or in combination
  91. Is There a Relationship between Maxillary Sinus Findings and Skeletal Malocclusion?
  92. AB0597 Adaptation of Ucla Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Questionnaire into Turkish
  93. Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis
  94. Risk factors for malignancy in systemic sclerosis patients
  95. Increased Frequency of Hand Osteoarthritis in Patients with Primary Sjögren Syndrome Compared with Systemic Lupus Erythematosus
  96. Effect of sex steroids on bone formation in an orthopedically expanded suture in rats
  97. Bilateral orbital pseudotumor in a patient with Takayasu arteritis: a case report and review of the literature
  98. The effect of fixed appliances on oral malodor from beginning of treatment till 1 year
  99. Minor salivary gland evaluation: Sjögren’s syndrome
  100. A relationship between spinal new bone formation in ankylosing spondylitis and the sonographically determined Achilles tendon enthesophytes
  101. Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis
  102. Prevalence of Inflammatory Back Pain and Axial Spondyloarthritis Among University Employees in Izmir, Turkey
  103. FRI0210 A Lower Frequency of Inflammatory Back Pain in Male Patients with Ankylosing Spondylitis Compared with Female Patients
  104. SAT0261 Asdas can be Reliably Calculated When Only the Patient's Overall Basdai Score is Available, but not the Score(S) of its Individual Component(S): Table 1.
  105. AB1120 Comparison of Long-Term Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis: A Single Center Turkish Experience Over a Decade
  106. FRI0229 Evaluation of Patient Acceptable Symptom State in Patients with Axial Spondylarthritis; Similar Thresholds for Radiographic and Non-Radiographic Subgroups
  107. AB0764 Gender Differences in Axial Spondyloarthritis
  108. FRI0260 The Assessment of Disease Activity in Takayasu Arteritis; Six Years Experience from a Single Center: Table 1.
  109. FRI0227 The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups: Table 1.
  110. Telephone interview strategy can be used for screening inflammatory back pain in the community
  111. Morphological Nasal Changes Associated with Rapid Maxillary Expansion
  112. Body composition in patients with rheumatoid arthritis is not different than healthy subjects
  113. Efficacy of Interleukin-1 Targeting Treatments in Patients with Familial Mediterranean Fever
  114. FRI0148 Family History in Turkish Ankylosing Spondylitis Patients Receiving Anti-TNF Therapy: Table 1.
  115. AB0712 Level of Awareness of Inflammatory Back Pain and Axial Spondyloarthritis among Medical Specialties Who Frequently SEE Patients with Low Back Pain
  116. SAT0361 Short Term Efficacy of Tumor Necrosis Factor Inhibitors in Patients with Non–Radiographic Axial Spondylarthritis and Ankylosing Spondylitis; Results from TURKBIO Registry: Table 1.
  117. AB0744 There is NO Relationship between Glucagon like Peptide-1 and Inflammation in Psoriasis and Psoriatic Arthritis: Table 1.
  118. Performance of different criteria sets for inflammatory back pain in patients with axial spondyloarthritis with and without radiographic sacroiliitis
  119. Familial Mediterranean fever: An updated review
  120. The prevalence of gout in an urban area of Izmir, Turkey: A population-based epidemiological study
  121. Echocardiographic Parameters Predicting the Mortality and Morbidity in Pulmonary Hypertension
  122. THU0225 Prevalence of takayasu’s arteritis in IZMIR, turkey: A multicenter study
  123. High frequency of inflammatory back pain and other features of spondyloarthritis in patients with rheumatoid arthritis
  124. Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis
  125. Increased prevalence of M694V in patients with ankylosing spondylitis: Additional evidence for a link with familial mediterranean fever
  126. Prevalence of primary Sjogren’s syndrome in Turkey: a population-based epidemiological study
  127. A Large-Scale Outbreak of Trichinellosis Caused byTrichinella britoviin Turkey
  128. M694V mutation may have a role in susceptibility to ankylosing spondylitis
  129. A Case of Adult-Onset Still's Disease Complicated with Diffuse Alveolar Hemorrhage
  130. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease
  131. Hyperuricemia and its related factors in an urban population, Izmir, Turkey
  132. Atypical infectious mononucleosis in a patient receiving tumor necrosis factor alpha inhibitory treatment
  133. Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy
  134. Clinical history for inflammatory back pain in ankylosing spondylitis: the sensitivity, specificity and consistency of clinical features
  135. Ankylosing spondylitis and spondylarthropathy presenting with a clinical picture of adult onset Still's disease: case series
  136. Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment
  137. Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients
  138. Irritable Bowel Syndrome in Persons Who Acquired Trichinellosis
  139. FREQUENCY AND SEVERITY OF MUSCULOSKELETAL SYMPTOMS IN HUMANS DURING AN OUTBREAK OF TRICHINELLOSIS CAUSED BY TRICHINELLA BRITOVI
  140. Body composition, insulin, and leptin levels in patients with ankylosing spondylitis
  141. Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever
  142. Reply
  143. Impaired endothelial function in patients with ankylosing spondylitis
  144. Acute Trichinellosis in Children Compared With Adults
  145. Reflex sympathetic dystrophy syndrome due to arteriovenous fistula
  146. Skewed X chromosome inactivation in blood cells of women with scleroderma
  147. Familial Mediterranean Fever (FMF) in Turkey
  148. Skewed X chromosome inactivation in scleroderma: Comment on the article by Özbalkan et al
  149. Thyrotoxic Periodic Paralysis in a Turkish Male; The Recurrence of the Attack after Radioiodine Treatment
  150. Thrombosis and priapism in a patient with Henoch-Schonlein purpura
  151. Articular, B-cell, non-Hodgkin?s lymphoma mimicking rheumatoid arthritis: synovial involvement in a small hand joint
  152. A case of recurrent pancreatitis due to hyperlipidemia misdiagnosed as familial Mediterranean fever
  153. Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder
  154. A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations
  155. Seroprevalence of Borrelia burgdorferi in patients with Beh�et's disease
  156. A case with recurrent calf pain and swelling: recurrent spontaneous calf haematoma
  157. Coexistence of familial Mediterranean fever with sacroiliitis and Behçet's disease: A rare occurrence